Comparison of immunotherapy with aeroallergens and drug treatment in patients with allergic rhinitis

Phase 3

Recruiting

• Conditions: Allergic rhinitis.; Allergic rhinitis, unspecified; J30.9

• Registration Number: IRCT20171030037093N15
• Lead Sponsor: Shahre-kord University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Age 10 and over 10 years
Age less than 50 years
Lack of advanced and severe asthma
Negative pregnancy test for women
Lack of autoimmune disease
Lack of immunodeficiency disease
Lack of malignancy

Exclusion Criteria

Patient lack of cooperation
Continuous use of immunosuppressive drugs
Continuous use of antihistamines
Taking beta-blocker medications
History of allergy to each of the treatment groups

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sneeze. Timepoint: Before intervention, 2 years after intervention. Method of measurement: Checklist containing clinical symptoms.;Cough. Timepoint: Before intervention, 2 years after intervention. Method of measurement: Checklist containing clinical symptoms.;Rhinorrhea. Timepoint: Before intervention, 2 years after intervention. Method of measurement: Checklist containing clinical symptoms.;Itchy eyes. Timepoint: Before intervention, 2 years after intervention. Method of measurement: Checklist containing clinical symptoms.;Itchy throat. Timepoint: Before intervention, 2 years after intervention. Method of measurement: Checklist containing clinical symptoms.;Post nasal discharge. Timepoint: Before intervention, 2 years after intervention. Method of measurement: Checklist containing clinical symptoms.;Nasal congestion. Timepoint: Before intervention, 2 years after intervention. Method of measurement: Checklist containing clinical symptoms.